Management

Rose C. Perri, President has held management and overseen operations for both private and public companies for the past 20+ years. She has served in a number of start-up biotech companies where her roles included those of principal shareholder, Senior Executive and Board Member. She, along with her late brother, E. Mark Perri, founded Biomin Therapeutics Corporation, a start-up biotech company, in 1990. Biomin was a publically-traded company both on the Toronto and Vancouver Stock Exchanges. Rose managed the day-to-day corporate affairs for this R&D biotech company whose research focused in the area of bone cancer treatments.In 1995, Rose was a co-founder of Generex Biotechnology Corporation, a start-up drug delivery company whose main research and development product was a buccal delivery of insulin. The company initially went public in February, 1998 and moved up Bulletin Board to SmallCaps to the NASDAQ Stock Exchange where it traded for over a decade. Her roles in the 16 years at Generex Biotechnology Corporation evolved from a co-Founder to holding her executive positions, namely Chief Operating Officer and Chief Financial Officer. Her positions have allowed her the opportunity to expand her network within the pharmaceutical, biotechnology, regulatory and financial industries. She will utilize her resources in this area to attract and manage various potential partnerships and alliances.She has also served as a manager of a family-owned property investment/property management and investment company with responsibilities of overseeing the portfolio. This business has been operational since the 1980’s and continues to exist and operation to this present day.